Spur Therapeutics today announced updated clinical data for avigbagene parvec (FLT201), its Gaucher disease gene therapy candidate, demonstrating clinical benefit and favorable safety maintained for ...
With 20% off the entire Dr. Diamond Metacine InstaFacial line, there’s no better time than the present to shop these rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback